Company Description
ROCKET PHARMACEUTICALS (NASDAQ: RCKTW) is classified in the Pharmaceutical Preparations sector.
RCKTW has declined 92.0% over the past year. Shares last traded at $0.0033.
For FY2025, ROCKET PHARMACEUTICALS reported revenue of $0 with net income of -$223.1M and diluted earnings per share of $-2.01.
This page collects what Stock Titan holds for RCKTW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ROCKET PHARMACEUTICALS (RCKTW) stock last closed at $0.0033. Over the past 12 months, the stock has lost 92.0%.
RCKTW Rankings
Latest News
SEC Filings
ROCKET PHARMACEUTICALS has filed 5 recent SEC filings, including 3 Form 4, 1 Form 3, 1 Form 144. The most recent filing was submitted on July 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RCKTW SEC filings →
Financial Highlights
operating income reached -$231.7M, and net income was -$223.1M. Diluted earnings per share stood at $-2.01. The company generated -$190.0M in operating cash flow. With a current ratio of 6.38, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in ROCKET PHARMACEUTICALS (RCKTW) currently stands at 146.4 thousand shares, up 3848.2% from the previous reporting period. Since July 2025, short interest has increased by 6405.5%.
Days to Cover History
Days to cover for ROCKET PHARMACEUTICALS (RCKTW) currently stands at 2.9 days, up 190% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 190% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 29.8 days.
RCKTW Company Profile & Sector Positioning
ROCKET PHARMACEUTICALS (RCKTW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.